Episode Synopsis "Differentiating Oral DMTs to Optimize Treatment Individualization with Drs. Stephen Krieger and Patricia K. Coyle"

In this podcast, expert clinicians will revisit an important topic from MS Forum® VIII, the use of current and emerging oral therapies for MS, including the Burton’s tyrosine kinase (BTK) inhibitors.

Listen "Differentiating Oral DMTs to Optimize Treatment Individualization with Drs. Stephen Krieger and Patricia K. Coyle"

More episodes of the podcast MedEdTalks - Neurology

• Exploring the Latest Data on Targeted Therapies for Treating gMG With Drs. Nicholas Silvestri and Kelly Gwathmey
• Unraveling the Pathophysiology of gMG and Its Impact on Treatment Selection With Drs. Nicholas Silvestri and Carolina Barnett-Tapia
• Understanding Disease Burden and Severity in gMG With Drs. Nicholas Silvestri and Neelam Goyal
• Incorporating Patient-Centered Care in Treatment Decisions With Drs. Stuart Isaacson and Rajesh Pahwa
• Available and Novel Therapies for Nonmotor Symptoms in Parkinson’s Disease With Drs. Pahwa and Armstrong
• Current and Emerging Treatment Options for Motor Symptoms in Parkinson’s Disease With Drs. Rajesh Pahwa and Stuart Isaacson
• Staging and Monitoring Parkinson’s Disease With Drs. Rajesh Pahwa and David Standaert
• Differentiating Oral DMTs to Optimize Treatment Individualization with Drs. Stephen Krieger and Patricia K. Coyle
• Gender-based Issues in MS and the Role of Patient-Provider Communication With Dr. Patricia K. Coyle and Dana Hernandez
• Progressive MS: Selecting Optimal Treatments, With Patricia K. Coyle, MD, FAAN, FANA; and Clyde E. Markowitz, MD
• Relapsing MS: Improving Patient Recognition With Patricia K. Coyle, MD, FAAN, FANA; and Stephen Krieger, MD, FAAN
• MS and the Family Planning Process: Opening Up the Discussion, With Patricia Melville and Patricia K. Coyle, MD, FAAN, FANA
• Current and Emerging Agents: Applying the Latest Evidence With Patricia K. Coyle, MD, FAAN, FANA; and Clyde E. Markowitz, MD
• MS Care During a Pandemic: COVID-19 and Telehealth, With Patricia K. Coyle, MD, FAAN, FANA; and Stephen Krieger, MD, FAAN
• The Future Treatment Landscape of Alzheimer’s Disease With Drs. Raymond Scott Turner and Marwan Noel Sabbagh
• Current Therapies for Alzheimer’s Disease With Drs. Raymond Scott Turner and Marwan Noel Sabbagh
• Understanding the Pathophysiology of Alzheimer’s Disease With Drs. Raymond Scott Turner and Sharon Cohen
• The Critical Importance of Early Diagnosis of Alzheimer’s Disease With Drs. Raymond Scott Turner and Sharon Cohen
• MS Forum® VI: Applying the Latest Data and Advanced Communication to Individualize Treatment and Improve Quality Care -- Long-term Outcomes with Established Therapies
• MS Forum® VI: Applying the Latest Data and Advanced Communication to Individualize Treatment and Improve Quality Care -- Immune Reconstitution
• MS Forum® VI: Applying the Latest Data and Advanced Communication to Individualize Treatment and Improve Quality Care -- Shared Decision-making
• MS Forum® VI: Applying the Latest Data and Advanced Communication to Individualize Treatment and Improve Quality Care -- S1P Receptor Modulators in RRMS
• MS Forum® VI: Applying the Latest Data and Advanced Communication to Individualize Treatment and Improve Quality Care -- MS in Pregnancy
• MS Forum® VI: Applying the Latest Data and Advanced Communication to Individualize Treatment and Improve Quality Care -- Monoclonals in Progressive MS
• MedEd Talks in Neurology - MS Forum VI: Applying the Latest Data and Advanced Communication to Individualize Treatment and Improve Quality Care